OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
46
Results
Show all
Save search
Copy query
Show results for
Unknown
(46)
Publication Date
Release Date
2023
(11)
2024
(9)
2025
(7)
2021
(6)
2022
(5)
2019
(3)
2026
(1)
2020
(1)
2018
(1)
2017
(1)
2013
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
Single-cell profiling reveals the importance of CXCL13/CXCR5 axis biology in lymphocyte-rich classic Hodgkin lymphoma.
Not available
S-EPMC8521678
|
biostudies-literature
Cite
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer.
Not available
S-EPMC10071693
|
biostudies-literature
Cite
Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time.
Not available
S-EPMC10958387
|
biostudies-literature
Cite
Proteomic Evolution from Acute to Post-COVID-19 Conditions.
Not available
S-EPMC10775146
|
biostudies-literature
Cite
Accelarated immune ageing is associated with COVID-19 disease severity.
Not available
S-EPMC10782727
|
biostudies-literature
Cite
Acetaminophen for Prevention and Treatment of Organ Dysfunction in Critically Ill Patients With Sepsis: The ASTER Randomized Clinical Trial.
Not available
S-EPMC11304120
|
biostudies-literature
Cite
Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.
Not available
S-EPMC7616743
|
biostudies-literature
Cite
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial.
Not available
S-EPMC12274867
|
biostudies-literature
Cite
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.
Not available
S-EPMC10527239
|
biostudies-literature
Cite
Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Not available
S-EPMC11390031
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets